Efficacy of Selumetinib in Reducing Plexiform Neurofibroma Volume in Adults with Neurofibromatosis Type 1 By Ogkologos - July 1, 2025 621 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the KOMET study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR Adagrasib Shows Clinical Efficacy in Patients with Previously Treated KRASG12C-Mutated Advanced... June 9, 2022 Cancer Research UK reports record levels of investment in its spinouts August 24, 2021 As Winter Storms Plague Southern States, GreaterGood Is Helping Where It’s... February 25, 2021 Cancer Patient’s Appetite Increases And His Blood Pressure Lowers After A... September 24, 2019 Load more HOT NEWS Cancer in My Community: The Roadblocks to Receiving Cancer Care in... Free Rides to Screening Appointments Thanks to Woman Who Lost Mother... Mortality Trends for Most Cancers Remain Favourable In the EU, Although... ΚΑΡΚΙΝΟΣ ΤΟΥ ΠΡΟΣΤΑΤΗ
